Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations

被引:94
作者
Groenning, BA
Nilsson, JC
Sondergaard, L
Pedersen, F
Trawinski, J
Baumann, M
Larsson, HBW
Hildebrandt, PR
机构
[1] Univ Copenhagen, Hvidovre Hosp, Danish Res Ctr Magnet Resonance, Sect 340, DK-2650 Hvidovre, Denmark
[2] Univ Copenhagen, Frederiksberg Hosp, Dept Cardiol & Endocrinol, Frederiksberg, Denmark
[3] F Hoffmann La Roche Ltd, Integrated Hlth Care Solut, Basel, Switzerland
关键词
D O I
10.1067/mhj.2002.122168
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Brain- and N-terminal pro brain natriuretic peptide (NT-proBNP) have been identified as promising markers for heart failure. However, previous studies have revealed that they may hold insufficient diagnostic power for implementation into clinical practice because of a significant overlap in the range of plasma levels between healthy subjects and subjects with heart failure. We hypothesized that imprecision of the reference method lie, the echocardiographic evaluation of left ventricular [LV] function) may have affected results from those earlier studies. We therefore wanted to investigate the diagnostic potential of NT-proBNP with magnetic resonance imaging as the reference method for the cardiac measurements. Methods Forty-eight patients with stable symptomatic heart failure in New York Heart Association functional classifications II to IV were examined once with blood samples and magnetic resonance imaging along with 20 age-matched and gender-matched healthy control subjects. Results NT-proBNP was associated with LV end-diastolic (r = 0.69; P < .0001) and end-systolic (r = 0.73; P < .0001) volume indices, LV mass index (r = 0.69; P < .0001), and LV ejection fraction (r = -0.75; P < .0001). Receiver operating characteristic curves were calculated for the ability of NT-proBNP to detect LV end-diastolic volume index (>105 mL.m(-2)[cut-offl; sensitivity/specificity, 82%/87%), LV end-systolic volume index (>35 mL.m(-2); sensitivity/specificity, 86%/86%), LV mass index (>152 g.m(-2); sensitivity/specificity, 85%/86%), and LV ejection fraction (<58%; sensitivity/specificity, 84%/85%) deviating more than 2 standard deviations from control values. Conclusion NT-proBNP is a powerful marker for LV dimensions and systolic function in patients with heart failure and discriminates well between healthy subjects and subjects with impaired LV systolic function or increased LV dimensions.
引用
收藏
页码:923 / 929
页数:7
相关论文
共 27 条
[1]   CINEANGIOGRAPHY OF THE HEART IN A SINGLE BREATH HOLD WITH A SEGMENTED TURBOFLASH SEQUENCE [J].
ATKINSON, DJ ;
EDELMAN, RR .
RADIOLOGY, 1991, 178 (02) :357-360
[2]   Incidence and aetiology of heart failure - A population-based study [J].
Cowie, MR ;
Wood, DA ;
Coats, AJS ;
Thompson, SG ;
Poole-Wilson, PA ;
Suresh, V ;
Sutton, GC .
EUROPEAN HEART JOURNAL, 1999, 20 (06) :421-428
[3]   Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care [J].
Cowie, MR ;
Struthers, AD ;
Wood, DA ;
Coats, AJS ;
Thompson, SG ;
PooleWilson, PA ;
Sutton, GC .
LANCET, 1997, 350 (9088) :1349-1353
[4]   PLASMA BRAIN NATRIURETIC PEPTIDE IN ASSESSMENT OF ACUTE DYSPNEA [J].
DAVIS, M ;
ESPINER, E ;
RICHARDS, G ;
BILLINGS, J ;
TOWN, I ;
NEILL, A ;
DRENNAN, C ;
RICHARDS, M ;
TURNER, J ;
YANDLE, T .
LANCET, 1994, 343 (8895) :440-444
[5]  
Groenning BA, 2001, EUR HEART J, V22, P395
[6]  
Guyton A C., TXB MED PHYSL
[7]  
Hjalmarson Å, 1999, LANCET, V353, P2001
[8]   Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): A new marker of cardiac impairment [J].
Hunt, PJ ;
Richards, AM ;
Nicholls, MG ;
Yandle, TG ;
Doughty, RN ;
Espiner, EA .
CLINICAL ENDOCRINOLOGY, 1997, 47 (03) :287-296
[9]  
Karl J, 1999, SCAND J CLIN LAB INV, V59, P177
[10]   Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: Evidence from a population-based study [J].
Luchner, A ;
Burnett, JC ;
Jougasaki, M ;
Hense, HW ;
Riegger, GAJ ;
Schunkert, H .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (07) :1839-1844